Non-Hodgkin Lymphoma
New non-hodgkin lymphoma study findings recently were published by E. Kalinkawarzocha and co-researchers
Published in Biotech Business Week, August 11th, 2008
"The objective of this study was to compare the efficacy of 3 regimens, cladribine alone, cladribine and cyclophosphamide combination, or cyclephosphamide, vincristine, and prednisone combination in previously untreated patients with low-grade B-cell non-Hodgkin lymphoma (LGNHL). For this 3-arm, phase 3 study, 197 patients were randomly allocated to receive 6 monthly courses of cladribine alone, cladribine and cyclophosphamide combination, or cyclophosphamide, vincristine, and prednisone combination," scientists in Warsaw, Poland report.
"Patients for whom all clinical data were available and 162 patients who completed scheduled chemotherapy were analyzed for the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Cancer Society
Hip bone density helps predict breast cancer risk - American Cancer Society
Prostate cancer patients undergoing hormone therapy may experience cognitive effects - American Society for Gastrointestinal Endoscopy
Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia - BioMed Central
Cholesterol-lowering drug boosts bone repair - BioMed Central
Frankincense provides relief to arthritis sufferers - BioMed Central
Gummy bears that fight plaque - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
